This hypothesis is based on the idea that VVX001 can induce preS-specific antibodies which may interrupt recurrent infection of liver cells in the course of CHB and additionally generate “mild” preS-specific CD4+ and CD8+ T-cell responses as was observed in grass pollen allergic patients vaccinated with BM32 [12]. Here, CD4 is linked to infection.